Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Chile Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20083
20092
20101
20121
20133
20192
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated5
Enrolling by invitation1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion6
United Therapeutics4
Aerovate Therapeutics2
Pfizer2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
GB002, Inc.1
Gilead Sciences1
Gossamer Bio USA, Inc.1
University of Chile1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension20
Hypertension, Pulmonary6
Cardiovascular Diseases2
Connective Tissue Diseases2
Eisenmenger Complex2
Familial Primary Pulmonary Hypertension2
Hypertension2
Lung Diseases2
Respiratory Tract Diseases2
Vascular Diseases2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.